The #cholangiocarcinoma (bile duct cancer) #market is developing due to rising incidence rates, enhanced diagnostic capabilities, and increased public awareness. Advances in targeted medicines, immunotherapy, and personalised medicine are propelling treatment innovation, while continuing clinical trials and regulatory approvals continue to change the competitive environment. https://theomnibuzz.com/cholangiocarcinoma-market-to-develop-new-growth-and-opportunities-analysis-story